The present invention relates to novel agents pharmaceutical compositions containing them and their use in therapy particularly anti microbial and anti cancer therapy. In particular the present invention relates to novel peptide based compounds based on SEQ ID NO:40 which have surprisingly been shown to have inhibitory effects on the growth and/or viability of cells particularly bacterial and cancer cells. Also provided are therapeutic and non therapeutic methods which comprise the use of peptides of the invention.
